Senior insider sale
CG ONCOLOGY, INC. — senior position signals high conviction
$2.50M
69.01K shares
What this filing means
MULAY JAMES plans to sell 69.01K shares of CG ONCOLOGY, INC. valued at approximately $2.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/9/2025ACC: 0001950047-25-007869
69.01K
Shares to sell
$2.50M
Approx. market value
6.56K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
10/9/2025
6.56KTotal acquired6.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/9/2025 | Exercise of Stock Options Cash | 6.56K | — |
| Total | 6.56K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
12.76K
Market value
$499.9K
9/29/2025
—Completed
Units to sell
3.57K
Market value
$139.4K
9/19/2025
—Completed
Units to sell
19.11K
Market value
$745.6K
9/18/2025
—Completed
Units to sell
27.02K
Market value
$851.8K
9/5/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.56K
Market value
$266.9K
10/9/2025
Total
Units
69.01K
Value
$2.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/29/2025 | 12.76K | $499.9K | — | Completed |
9/19/2025 | 3.57K | $139.4K | — | Completed |
9/18/2025 | 19.11K | $745.6K | — | Completed |
9/5/2025 | 27.02K | $851.8K | — | Completed |
| Planned — Approximate Date | ||||
10/9/2025 | 6.56K | $266.9K | NASDAQ | Planned |
| Total | 69.01K | $2.50M | ||